Remoxipride hydrochloride

This classification denotes a dopamine antagonist with the molecular formula C16H23BrN2O3.ClH.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier MH4OU8RWCW, chemically known as (-)-(s)-3-bromo-n-((1-ethyl-2-pyrrolidinyl)methyl)-2,6-dimethoxybenzamide monohydrochloride, monohydrate but more generally known as remoxipride hydrochloride, which bears US NIH Compound Identifier 60678. Most nations, for tariff and trade purposes, schedule remoxipride hydrochloride under HS 29339990 and SITC 51577. As of Q4 2014, REMOXIPRIDE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Remoxipride hydrochloride bears US NLM identifiers UMLS ID C0771022 and NCI Concept Code C73832. SMILES: CCN1CCC[C@H]1CNC(=O)C2C(CCC(C2OC)BR)OC.O.CL.